Clinical Trials · NCT01784965
Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Stanford University
- Enrollment
- 69
- Start date
- Dec 2009
- Locations
- See registry
- Primary endpoint
- Change in Weight Reported at 14 Weeks